Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Eli Lilly and Co
Recent news which mentions Eli Lilly and Co
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
European drug regulator rejects Alzheimer's treatment Leqembi from Biogen, Eisai
July 26, 2024
Tags
Science
Business News
Eisai Co Ltd
From
CNBC.com News
Viking Therapeutics stock jumps 16% after drugmaker moves weight loss injection to late-stage trial
July 25, 2024
Tags
Breaking News: Business
Business News
Biotech and Pharmaceuticals
From
CNBC.com News
Jim Cramer supports megacaps for the long term, even as Wall Street continues to sell
July 18, 2024
Tags
Amazon/com Inc
Meta Platforms Inc
Business News
From
CNBC.com News
CNBC Daily Open: Rising geopolitical risk
July 18, 2024
Tags
Inflation
World Markets
Technology
From
CNBC.com News
CNBC Daily Open: Rising geopolitical risk
July 17, 2024
Tags
Eli Lilly and Co
Obesity
Daily Open
From
CNBC.com News
Novo Nordisk and Eli Lilly shares slide on new obesity drug trial from Roche
July 17, 2024
Tags
Markets
Roche Holding AG
Zealand Pharma A/S
From
CNBC.com News
Healthy Returns: Diabetes drug Ozempic may lower dementia risk, nicotine use
July 16, 2024
Tags
UnitedHealth Group Inc
Pfizer Inc
Biotech and Pharmaceuticals
From
CNBC.com News
Healthy Returns: Drugmakers are racing to develop more convenient weight loss pills
July 11, 2024
Tags
Biotech and Pharmaceuticals
Novo Nordisk A/S
Healthy Returns
From
CNBC.com News
Pfizer moves forward with once-daily version of weight loss pill after setbacks
July 11, 2024
Tags
Health & Science
Pharmaceuticals
Pfizer Inc
From
CNBC.com News
Jim Cramer on Hims & Hers Health stock: 'I bet the business stays strong'
July 10, 2024
Tags
Hims & Hers Health Inc
Stock Picks
Markets
From
CNBC.com News
Jim Cramer reviews 8 companies that could top $1 trillion in market cap
July 10, 2024
Tags
Investment Strategy
NVIDIA Corp
Meta Platforms Inc
From
CNBC.com News
FTC to sue drug middlemen over prices of medications including insulin
July 10, 2024
Tags
Biotechnology
Biotech and Pharmaceuticals
Sanofi SA
From
CNBC.com News
Companies besides tech can reach megacap status, Jim Cramer says
July 08, 2024
Tags
Business News
Meta Platforms Inc
Amazon/com Inc
From
CNBC.com News
This ETF is trying to satisfy appetites for weight loss stocks
July 06, 2024
Tags
Weight management
U/S/ Markets
Stock markets
From
CNBC.com News
Healthy Returns: Brain implant company Paradromics launches patient registry ahead of human trial
July 03, 2024
Tags
Health & Science
Viking Therapeutics Inc
Gilead Sciences Inc
From
CNBC.com News
CNBC Daily Open: Tesla soars, S&P closes above 5,500
July 03, 2024
Tags
World Markets
Medication
Technology
From
CNBC.com News
CNBC Daily Open: Tesla soars, S&P closes above 5,500
July 02, 2024
Tags
World Markets
Technology
Medication
From
CNBC.com News
FDA approves Eli Lilly Alzheimer’s drug, expanding treatment options in the U.S.
July 02, 2024
Tags
Companies
Business
Health care industry
From
CNBC.com News
Watch now: ETF Edge on reshoring trends, weight loss drugs and more
July 01, 2024
Tags
Investment strategy
ETF Edge
Amgen Inc
From
CNBC.com News
Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data
June 26, 2024
Tags
Health & Science
Viking Therapeutics Inc
Gilead Sciences Inc
From
CNBC.com News
Jim Cramer's top picks for pet-centric stocks
June 25, 2024
Tags
Investing
Eli Lilly and Co
U/S/ Markets
From
CNBC.com News
Novo Nordisk's Wegovy weight loss drug approved in China
June 25, 2024
Tags
Europe News
Business
Asia News
From
CNBC.com News
Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, Ozempic
June 24, 2024
Tags
Biotechnology
Biotech and Pharmaceuticals
US: News
From
CNBC.com News
Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early as end of the year
June 21, 2024
Tags
Companies
Health care industry
Pharmaceuticals
From
CNBC.com News
Weight loss drug contender Zealand Pharma jumps 23% on trial results
June 21, 2024
Tags
Europe News
Markets
Zealand Pharma A/S
From
CNBC.com News
Healthy Returns: More U.S. employers are now covering GLP-1s for weight loss
June 18, 2024
Tags
Novo Nordisk A/S
Eli Lilly and Co
Biotech and Pharmaceuticals
From
CNBC.com News
How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi
June 17, 2024
Tags
Business
Health care industry
Companies
From
CNBC.com News
Jim Cramer says Eli Lilly isn't a 'one trick pony' after FDA advisers endorse its Alzheimer's drug
June 11, 2024
Tags
Business
Biogen Inc
Investment strategy
From
CNBC.com News
FDA advisors recommend Eli Lilly's Alzheimer's drug donanemab, paving way for approval
June 10, 2024
Tags
US: News
Eli Lilly and Co
Business News
From
CNBC.com News
Jim Cramer's week ahead: Fed meeting and CPI report
June 07, 2024
Tickers
RH
Tags
Markets
Stock Picks
Casey's General Stores Inc
From
CNBC.com News
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.